New Lilly Head Lechleiter Streamlines Operations
This article was originally published in The Pink Sheet Daily
Exec, who assumed CEO role April 1, takes steps to eliminate "bureaucracy" in U.S., R&D units.
You may also be interested in...
As president and chief operating officer since October 2005, Lechleiter has been groomed for the post.
Goal is to launch an average of two products per year by 2011 and three a year starting in 2014, CEO Taurel says.
Adiana uses a polymer matrix insert to block the fallopian tubes instead of a metal coil, offering a benefit over Essure, which carries a perforation risk on implantation, Hologic exec says.